Kynam Capital Management, LP CLDX Holdings History
Kynam Capital Management, LP's Celldex Therapeutics Inc Holding Summary
As of 2025-03-31, Kynam Capital Management, LP held 6.50 Mil shares of Celldex Therapeutics Inc(CLDX), totaling $117.97 Mil. This investment constitutes 9.91% of their stock portfolio, and Kynam Capital Management, LP now holds 9.79% of the outstanding Celldex Therapeutics Inc(CLDX) stock.
The initial trade took place in 2021Q4. And since then Kynam Capital Management, LP has made 10 purchases of CLDX, at an average price of $29.71, for a total of 7.00 Mil shares. In addition, there have been 3 sales at an average price of $37.33 for 495,939.00 shares. Based on historical transaction data and CLDX's current price of $20.29, Kynam Capital Management, LP's estimated gain on his CLDX holdings is $-57.46 Mil, reflecting a -27.64% gain to date.
Kynam Capital Management, LP CLDX ($20.29) Holding Chart
Kynam Capital Management, LP CLDX ($20.29) Quarterly Buys and Sells
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
|---|---|---|---|---|
| Shares Bought | 0 | Average Price $-/Share | ||
| Shares Sold | 0 | Average Price $-/Share | ||
| Current Price $0.00 | Total Estimated Gain 0 % | |||
Top Ranked Articles
- 1
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
